SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-089593
Filing Date
2021-03-22
Accepted
2021-03-22 16:29:52
Documents
4
Period of Report
2021-03-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d242363d8k.htm 8-K 26960
2 EX-10.1 d242363dex101.htm EX-10.1 146260
3 EX-99.1 d242363dex991.htm EX-99.1 13371
4 GRAPHIC g242363g29g19.jpg GRAPHIC 4950
  Complete submission text file 0001193125-21-089593.txt   194905
Mailing Address 139 MAIN STREET, SUITE 500 CAMBRIDGE MA 02142
Business Address 139 MAIN STREET, SUITE 500 CAMBRIDGE MA 02142 (617) 433-2605
Allovir, Inc. (Filer) CIK: 0001754068 (see all company filings)

IRS No.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39409 | Film No.: 21761657
SIC: 2836 Biological Products, (No Diagnostic Substances)